Company intelligence / Profile preview

Carmeda

Solna, Stockholm County, Swedencarmeda.se ↗

Ownership: Private
Development stage: Commercial

Overview

The CARMEDA® BioActive Surface has been clinically proven to reduce thrombus formation and improve outcomes for millions of patients worldwide. Products featuring this coating are market leaders in their fields and have demonstrated improved clinical results compared to untreated alternatives.

Therapeutic areas: CardiovascularHematology
Modalities: DevicePolymer-drug conjugate therapy
Industry: Chemicals & Materials

Partnerships

Stryker Neurovascular division

Beyond the preview

Go deeper on Carmeda.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Carmeda.

Explore the full profile